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Abstract
Background: Plasmodium vivax, although causing a less serious disease than Plasmodium falciparum,
is the most widespread of the four human malarial species. Further to the recent recrudescence of
P. vivax cases in the Newly Independent States (NIS) of central Asia, a survey on the genetic
diversity and dissemination in Azerbaijan was undertaken. Azerbaijan is at the crossroads of Asia
and, as such, could see a rise in the number of cases, although an effective malaria control
programme has been established in the country.
Methods: Thirty-six P. vivax isolates from Central Azerbaijan were characterized by analysing the
genetic polymorphism of the circumsporozoite protein (CSP) and the merozoite surface protein 1
(MSP-1) genes, using PCR amplifications and amplicons sequencing.
Results: Analysis of CSP sequences showed that all the processed isolates belong to the VK 210
type, with variations in the alternation of alanine residue (A) or aspartic acid residue (D) in the
repeat motif GDRA(A/D)GQPA along the sequence. As far as MSP-1 genotyping is concerned, it
was found that the majority of isolates analysed belong to Belem and Sal I types. Five recombinant
isolates were also identified. Combined analysis with the two genetic markers allowed the
identification of 19 plasmodial sub-types.
Conclusion: The results obtained in the present study indicate that there are several P. vivax
clones circulating in Azerbaijan and, consequently, a careful malaria surveillance could be of
paramount importance to identify, at early stage, the occurrence of possible P. vivax malaria
outbreaks.
Introduction
Plasmodium vivax is the most widely distributed human
parasite, with an estimated burden of 70–80 million cases
annually [1]. In some parts of the world (Asia, South
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America), it is the most prevalent form of the four human
malarial parasites. Although it causes a less severe disease
than Plasmodium falciparum, being rarely lethal, P. vivax
affects the working capacity of the population and the lack
of efficient drug distribution favors the onset of drug
resistant strains [2,3]. Imported malaria is an increasing
health problem in Western Europe, where about 6,500
cases are reported annually in Germany, France, Italy and
the United Kingdom [4]. Although P. falciparum infec-
tions account for the majority of cases (64%), P. vivax is
responsible for an additional 23% [4]. Presence in this
area of residual anopheline populations susceptible to P.
vivax infection represents a permanent risk for the occur-
rence of P. vivax indigenous malaria cases, as recently
occurred in central Italy [5,6]. Since 1970, malaria had
been eradicated in central Asia, except for some residual
foci in two countries belonging to the Newly Independent
States (NIS), i. e. Azerbaijan and Tajikistan (WHO,
Regional Office for Europe, unpublished document). At
the beginning of the 1990s, the situation changed dramat-
ically due to the re-emergence of malaria in the NIS area
and especially in Tajikistan, where at present an epidemic
is still in progress [7,8]. In these countries, the existing
state of the primary health care system is extremely precar-
ious, especially in rural areas and in small villages. Malaria
is a common disease, which can easily re-establish itself
when a lack of control occurs.
In comparison with P. falciparum, molecular studies of the
genetic diversity and dissemination of P. vivax are scanty.
Recently, 33 polymorphic tandem repeats (TRs) of P. vivax
and a P. vivax polymorphic microsatellite have been iden-
tified and shown to be useful in population studies [9,10].
The merozoite surface protein 3α (MSP3-α) gene also
seems to be a good candidate for studying the genetic
diversity of P. vivax populations, since PCR-RFLP products
indicate the presence of up to 13 alleles [11,12]. However,
the circumsporozoite protein (CSP) and merozoite sur-
face protein 1 (MSP-1) genes still remain the most studied
molecular markers in genetic epidemiological surveys car-
ried out in P. vivax endemic areas.
In the frame of a malaria research project funded by the
European Commission, a molecular study was under-
taken in Azerbaijan, aimed at collecting information on
the genetic make-up of P. vivax natural populations
present in this endemic country. For this purpose the
extent of polymorphism of CSP and MSP-1 genes were
analysed in parasite isolates from five localities of central
Azerbaijan by using PCR amplification and sequencing.
Materials and Methods
Study area and samples collection
Azerbaijan covers an area of 29.540 Km2, with a popula-
tions of approximatively 2,5 millions. The climate is typi-
cally continental with an average temperature between 12
and 15°C and a rainfall between 200 and 600 mm per
year. Climatic and agro-ecological conditions of this area
make the environment favourable to mosquito vectors
breeding. The major malaria vector is Anopheles sacharovi
that breeds preferably in lakes, swamps, irrigation canals
and pools. Although it prefers well-oxygenated water, it is
known to tolerate moderate salty water. Other anopheline
species found in this area are A. maculipennis, A. subalpinus,
A. superpictus and A. hyrcanus, all of which are considered
secondary vectors of malaria transmission [13]. Malaria
transmission occurs in Azerbaijan mainly from June to
October. In the last years, number of malaria cases
showed a negative trend, accounting for 610 cases in
2000, 418 cases in 2001, 203 cases in 2002.
During summer 2002, a malaria epidemiological survey
was performed in central Azerbaijan, in the frame of a
Malaria Surveillance Programme launched in year 2001
by the Ministry of Health in collaboration with WHO.
Active case detection was carried out in five districts
included in previously identified sentinel sites, namely
Mingaçevir, Beylagan, Imisli, Saatli and Sabirabad. A map
of Azerbaijan with the study area is shown in Figure 1.
All individuals who visited the district health centres or
were found in villages with a history of recent fever and no
history of travel in the past few months were considered.
In this context, a total of 36 infected individuals with pos-
itives blood smears at the microscopic examination, col-
lected between August and September 2002, were selected
for the genetic study. The age of patients ranged from 6 to
78 years and parasitaemia varied from 288 to 12,800 par-
asites/µl. For the molecular analysis, a blood sample of
about 1 ml was taken from by venipuncture before drug
treatment was given. Patients or the guardians of children
were informed about the study. According to the interna-
tional rules for research involving human subjects, any
information which would identify a participant was
removed in order to keep each sample processed anony-
mous. Number of samples for each district is shown in
Table 1.
DNA preparation
Plasmodial DNA was extracted from 200 µl of each
infected blood sample using QIAamp DNA blood kit fol-
lowing the manufacturer's instructions (Qiagen, CA).
Circumsporozoite (CSP) marker analysis
The CSP gene was amplified for the most part of samples
using PV5 and PV6 primers [14]. Samples that did not
provide good PCR products with this set of primers were
processed a second time by using CSP-A2 [15] as forward
primer and PV6bis (5'-CACAGGTTACACTGCATGGAGT-
3') as original reverse primer. PCR amplification wasMalaria Journal 2004, 3:40 http://www.malariajournal.com/content/3/1/40
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performed in a reaction mixture of 50 µl containing the
parasite DNA, 1x reaction buffer, 2.5 mM MgC12, 80 µM
of each deoxynucleotide triphosphate, 6 pmol of each
primer and 1.3 U of Taq polymerase (Promega, Madison,
USA). The PCR programme was: denaturation at 94°C for
five minutes; 34 cycles of one minute at 94°C, one minute
at 54°C and two minutes at 72°C. The PCR products were
separated using electrophoresis on a 1.5 % NuSieve gel
and the band of interest was cut out and purified using the
QIAquick PCR purification Kit (Qiagen). The purified
product was sequenced in both directions using an ABI-
PRISM 373 sequencer. Nucleotide or amino acid
sequences were aligned first using the CLUSTAL X pro-
gramme [16] with manual editing and adjustments made
using the MUST package [17]. The ExPASy Molecular Biol-
ogy Server http://us.expasy.org/ was used to convert
nucleotide sequences into amino acid sequences. The
GenBank accession numbers of the eight sub-types of
VK210 type are from AY792359 to AY 792366.
Merozoite surface protein 1 (MSP-1) marker analyses
A portion of the MSP-1 gene (the region encompassing
the interspecies conserved blocks ICB5 and ICB6) was
amplified using a nested PCR with, respectively, the two
outer primers A5 and A6 [18] and the two inner primers
MSP1N1 forward and MSP1N2 reverse [6]. The first round
of amplification was performed in a reaction mixture of
50 µl containing parasite DNA, 1x reaction buffer, 2.5 mM
MgC12, 200 µM of each deoxynucleotide triphosphate, 30
pmol of each primer and 2.5 U of Taq  polymerase
(Promega, Madison, USA). For the second round, 10 µl of
the first amplification product was added to a fresh PCR
Map of central Azerbaijan showing localities (underlined names on the map) included in the present study Figure 1
Map of central Azerbaijan showing localities (underlined names on the map) included in the present study.Malaria Journal 2004, 3:40 http://www.malariajournal.com/content/3/1/40
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mixture with 30 pmoles of each inner primer. The thermal
profile was: denaturation at 94°C for five minutes; 35
cycles of 94°C for one minute, 60°C for one minute and
75°C for three minutes. All nested-PCR products were
purified by Microcon-PCR (Millipore), following the
manufacturer's instructions and sequenced in both direc-
tions at the MWG Biotech. The results were analysed by
means of Omiga 2.0 (ACCELRYS, Cambrige) and Mega 2
(S. Kumar, K. Tamura, M. Nei and Pennsylvania State Uni-
versity) computer programmes. The GenBank accession
numbers of the 36 nucleotide sequences from P. vivax iso-
lates are from AY789657 to AY789692.
Distance analyses
The aligned nucleotide sequences of CSP were converted
to a distance matrix (% of differences) using the Net algo-
rithm of the MUST package [17]. The dendrogram was
generated using the neighbour-joining method [19].
Bootstrap proportions were used to assess the robustness
of the tree with 1,000 bootstrap replications [20].
MSP-1 and CSP data were analysed using the Cavalli-
Sforza distance [21] from Genetics v.4.01 package. The
dendrogramme was generated using the neighbour-join-
ing method [19]
Results
CSP marker
CSP sequences obtained from 36 Azerbaijan P. vivax iso-
lates were found to belong to the VK210 type [22]. The
Table 1: Geographic origin of Azerbaijan isolates with the corresponding MSP-1 and CSP characteristics identified in the present study.
ISOLATE NAMES MSP-1 CSP
Genotype No. polyQ Sub-type Genotype Sub-type
Bey1 Belem 21 G VK210 4
Bey2 Belem 21 G " 4
Bey4 Sal1 - O " 5
Bey7 Belem 21 G " 8
Bey14 recombinant 19 S " 2
Im3 Belem 21 G " 4
Im5 Belem 21 G " 4
Im8 Sal1 - H " 1
Im9 Belem 21 G " 4
Im10 Belem 21 F " 4
Im11 Belem 21 G " 4
Im12 Belem 21 C " 4
Im14 Belem 21 D " 4
Im15 Belem 21 G " 4
Min1 Belem 21 G " 4
Min3 Belem 21 G " 4
Min6 Sal1 - L " 3
Min7 recombinant 19 S " 2
Min8 Sal1 - I " 2
Min9 Belem 21 G " 4
Min10 Sal1 - P " 6
Sat2 Belem 21 G " 4
Sat3 Belem 21 F " 4
Sat5 recombinant 18 U " 5
Sat7 recombinant 18 U " 5
Sat11 recombinant 12 T " 5
Sab1 Belem 21 G " 7
Sab2 Belem 21 A " 4
Sab4 Belem 21 B " 4
Sab6 Sal1 - M " 4
Sab7 Belem 21 G " 4
Sab8 Belem 21 G " 4
Sab10 Sal1 - M " 4
Sab12 Belem 21 G " 4
Sab13 Sal1 - R " 4
Sab15 Sal1 - Q " 4Malaria Journal 2004, 3:40 http://www.malariajournal.com/content/3/1/40
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isolates tested displayed variations in the peptide repeat
motifs GDRA(A/D)GQPA with different alternations of
non-synonymous codons GCT or GAT, respectively, cod-
ing for alanine (A) and aspartic acid (D) (Figure 2). All our
sequence types had the same three repeat units
(GDRAAGQPA) at the 3' end, identical to that of the
VK210 type. Furthermore four non-synonymous muta-
tions were found, one being the RDRADGQPA variant
(sequence named in the present study as sub-type 1),
already described in North Korean and Chinese isolates
[23]. In summary, eight different sub-types of VK 210
were observed (Figure 2 and Figure 4). Among all 36 azeri
isolates analysed, 24 isolates were found to have identical
sequence (sub-type 4, Table 1 and Figure 4). In particular,
the Beylagan (n = 5) and Mingaçevir (n = 7) isolates
appeared the most diversified since they displayed four
and five different sub-types respectively. The Imishli (n =
9), Saatli (n = 5) and Sabirabad (n = 10) isolates only
showed two different sub-types each-one. Figure 4 clearly
shows that the genetic diversity of CSP is relatively small
inside the Azerbaijan isolates when compared to the
South Korean and Chinese isolates.
MSP-1 marker
The majority of Azerbaijan isolates (Table 1) belong to
either the Belem (22 isolates, all with the same poly-Q
region of 21 repeats) or the Sal I (9 isolates) types already
described [24]. Only 5 P. vivax isolates were identified as
recombinant types. Isolate Satl1 (sequence named in the
present study as sub-type T) could be ascribed to the type
Amino acid sequence alignment of eight CSP sub-types found from 36 Azerbaijan P. vivax isolates with that of VK210 type  (Accession No. M28745) Figure 2
Amino acid sequence alignment of eight CSP sub-types found from 36 Azerbaijan P. vivax isolates with that of VK210 type 
(Accession No. M28745). a Imi 8; b Bey 14, Min 7, 8; c Min 6; d Bey 1, 2, Imi 3, 5, 9, 10, 11, 12, 14, 15, Min 1, 3, 9, Sat 2, 3 Sab 2, 
4, 6, 7, 8, 10, 12, 13, 15; e Bey 4, Sat 5, 7, 11; f Min 10; g Sab 1; h Bey 7.
VK 210       KLKQPAGDRADGQPAGDRADGQPAGDRADGQPAGDRAAGQPAGDRADGQPAGDRAAGQPAGDRADG
Sub-type 1   .....................................D........A........D........A.
Sub-type 2   .......................................................D........A.
Sub-type 3   ...................................................C...D........A.
Sub-type 4   ................................................................D.
Sub-type 5   ..............................................A...................
Sub-type 6   ............................A........D........A........D........A.
Sub-type 7   ..................................................................
Sub-type 8   .......................................................D........A.
VK 210        QPAGDRAAGQPAGDRADGQPAGDRAAGQPAGDRAAGQPAGDRADGQPAGDRAAGQPAGDRADGQP
Sub-type 1    .......D........A........D.................A........D....R...A...
Sub-type 2    .......D........A........D.................A.....................
Sub-type 3    .......D........A........D.................A.....................
Sub-type 4    ................A........D.................A........D........A...
Sub-type 5    ..................................D........A.....................
Sub-type 6    .......D........A........D.................A........D........A...
Sub-type 7    ................A........D.................A........D........A...
Sub-type 8    .......D........A........D.................A.....................
VK 210 AGDRAAGQPAGDRAAGQPAGDRAAGQPAGNGAGGQAAGGN
Sub-type 1     ........................................
Sub-type 2     ........................................
Sub-type 3     ........................................
Sub-type 4     ........................................
Sub-type 5     ........................................
Sub-type 6     ........................................
Sub-type 7     ...........Y..S.........................
Sub-type 8     .....................G..................Malaria Journal 2004, 3:40 http://www.malariajournal.com/content/3/1/40
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3a (accession no. D85252, [25]), while isolates Bey 14
and Min7 (sub-type S) and isolates Sat5 and Sat7 (sub-
type U) seem to be the result of recombinant events
between the recombinant type 3a and Sal I. All the three
recombinant types showed a different number of poly-Q
repeats (Table 1). In addition to these sources of diversity,
nucleotide substitutions could be observed, allowing the
identification of 17 sub-types (Table 1 and Figure 3). The
Imisli and Sabirabad districts appeared to be less diversi-
fied, accounting for five different genotypes for 9 isolates
and six genotypes for 10 isolates, respectively. Finally,
Saatli district was found to have the greatest variability,
with four different genotypes for 5 isolates.
Combined analysis between the two markers
By combining the results of genotyping obtained by CSP
and MSP-1, 19 P. vivax sub-types (Figure 5) were identi-
fied as circulating in the central region of Azerbaijan. The
sub-type named G/4 with the greatest representation (n =
14 isolates), was detected in all districts investigated. Gen-
otypes identified as M/4 and U/5 were observed twice in
the districts of Sabirabad and Saatli, respectively. Geno-
type F/4 was detected once in Imisli and Saatli districts, as
was for genotype S/2, detected once in Beylagan and Min-
gacevir districts.
Discussion and conclusions
For CSP, the main variations already reported in the liter-
ature consist of two variant sequences, VK210 and VK247
Amino acid sequence alignment of seventeen MSP-1 sub-types found from 36 Azerbaijan P. vivax isolates compared with that of  MSPlBelem (Accession No. M60807), MSPlSal1 (Accession No. M75674) and recombinant type 3a (D85252) Figure 3
Amino acid sequence alignment of seventeen MSP-1 sub-types found from 36 Azerbaijan P. vivax isolates compared with that of 
MSPlBelem (Accession No. M60807), MSPlSal1 (Accession No. M75674) and recombinant type 3a (D85252). Classification of 
Azeri isolates according to the different types is shown in Table 1.
MSP1Belem FIPKIESMIA TEKAKP--AA SAPVTSGQLL RGSSE-AATE VTTNAVTSED QQQQQ----- ---Q-----Q QQQQQQQQQQ QQQQQQSQVV PAPAGDAQQV
Sub-typeA .......... ...N..--.. L......... .....-.... .........V .....----- ---.-----. .......... ....--.... ..........
Sub-typeB .......... ......--.. .........F ...R.-.... .........V .....----- ---.-----. .......... ....--.... ..........
Sub-typeC .......... ......--.. .V........ .....-.... .........V .....----- ---.-----. .......... ....--.... ..........
Sub-typeD .......... ......--.. .......... .....-.... .......F.V .....----- ---.-----. .......... ....--.... ..........
Sub-typeF .......... ......--.. .......... .....-.... .........V .....----- ---.-----. .......... ....--.... ..........
Sub-typeG .......... ......--.. .......... .....-.... .........V .....----- ---.-----. .......... ....--.... ..........
MSP1Sal1  .......... ...N..TV.. ADI.AK..S. ..A..TGT.G N.V..Q.AVV .-P.HQVANA VTV.PGTTGH .A.GGEAET. TNSV.AA..Q QT...AGG..
Sub-typeH .......... ...N..TV.. ADI.AK..S. ..A..TGT.G N.V..Q.AVV ..P.HQVANA VTV.PGTTGH .A.GGEAET. TNSV.AA..Q QT...AGG..
Sub-typeI .......... ...N..TV.. ADI.AK..S. ..A..TGT.G N.V..Q.AVV ..P.HQVANA VTV.PGTTGH .A.GGEAET. TNSV.AA..Q QT...AGG..
Sub-typeL .......... ...NM.TV.. ADI.AK..S. ..A..TGT.G N.V..Q.AVV .-.P.QVANA VTV.PGTTGH .A.GGEAET. TNSV.AA..Q QT...AGG..
Sub-typeM .......... ...N..TV.. ADI.AK..S. ..A..TGT.G N.V..Q.AVV .....QVVNA VTV.PGTTGH .A.GGEAET. TNSV.AA..Q QT...AGG..
Sub-typeO .......... ...N..TV.. ADI.AK..S. ..A..TGT.G N.V..Q.AVV ..P.HQVANA VTV.PGTTGH .A.GGEAET. TNSV.AA..Q QT...AGG..
Sub-typeP .......... ...N..TV.. ADI.AK..S. ..A..TGT.G N.V..Q.AVV ..P.HQVANA VTV.PGTTGH .A.GGEAET. TNSV.AA..Q QT...AGG..
Sub-typeQ .......... ...N..TV.. ADI.AK..S. ..A..TGT.G N.V..Q.AVV .....QVVNA VTV.PGTTGH .A.GGEAET. TNSV.AA..Q QT...AGG..
Sub-typeR .......... ...N..TV.. ADI.AK..S. ..A..TGT.G N.V..Q.AVV .-P.HQVANA VTV.PGTTGH .A.GGEAET. TNSV.AA..Q QT...AGG..
D85252    .......... ...N..TV.. ADI.AK..S. ..A..TGT.G N.V..Q.AVV .....----- ---.-----. ......---. ....--.... ..........
Sub-typeS .......... ...N..TV.. ADI.AK..S. ..A..TGT.G N.V..Q.AVV .....----- ---.-----. .......... ..----.... ..........
Sub-typeT .......... ...N..TV.. ADI.AK..S. ..A..TGT.G N.V..Q.AVV .....----- ---.-----. .....----- ------.... ..........
Sub-typeU .......... ...N..TV.. ADI.AK..S. ..A..TGT.G N.V..Q.AVV .....----- ---.-----. .......... .-----.... ..........
MSP1Belem ISTQPTSQSA AP-GVSATPA P-----TPAA AAAPAPAMSK LEYLEKLLDF LKSAYACHKH IFVTNSTMDK KLLKEYELNA DEKTKINQNK CDELDLL
Sub-typeA .......... ..-....... .-----.... .......... .......... .......... ..L..-S... .......... .......... .......
Sub-typeB .......... ..-....... .-----.... .......... .......... .......... .......... .......... .......... .......
Sub-typeC .......... ..-....... .-----.... .......... .......... .......... .......... .......... .......... .......
Sub-typeD .......... ..-....... .-----.... .......... .......... .......... .......... .......... .......... .......
Sub-typeF .......... ..-....... .-----.... .......... .......... .......... .......V.. .......... .......... .......
Sub-typeG .......... ..-....... .-----.... .......... .......... .......... .......... .......... .......... .......
MSP1Sal1  A...TI..AP ..TQA.PE.. .AAPPS.... .V....T... .......... .......... ........K. E..DQ.K... ..QN...ET. .......
Sub-typeH A...T...AP ..TQA.PE.. .AVPPS.... .V........ .......... .......... ........K. E..DQ.K... Y.QN...ET. .......
Sub-typeI A...T...AP ..TQA.PE.. .AVPPS.... .V....T... ....Q..... .......... ........K. E..DQ.K... ..QN...ET. .......
Sub-typeL A...TI..AP ..TQA.PE.. .AAPPS.... .V....T... ....Q..... .......... ........K. E..DQ.K... ..QN...ET. .......
Sub-typeM A...T...AP ..TQA.PE.. .AVPPS.... .V....T... ....Q..... .......... ........K. E..DQ.K... ..QN..KE.. .......
Sub-typeO A...T...AP ..TQA.PE.. .AVPPS.... .V....T... ....Q..... .......... ........K. E..DQ.K... ..QN...ET. .......
Sub-typeP A...T...AP ..TQA.PE.. .AVPPS.... .V........ .......... .......... ........K. E..DQ.K... ..QN...ET. .......
Sub-typeQ A...T...AP ..TQA.PE.. .AVPPS.... .V....T... ....Q..... .......... ......P.K. E..DQ.K... ..QN...ET. .......
Sub-typeR A...TI..AP ..SQA.PE.. .AVPPS.... .V....T... ....Q..... .......... ........K. E..DQ.K... ..QN...ET. .......
D85252    .......... ..-....... .-----.... .......... .......... .......... .......... .......... .......... .......
Sub-typeS .......... ..-....... .-----.... .......... .......... .......... ........K. E..DQ.K... ..QN..KE.. .......
Sub-typeT .......... ..-D...... .-----.... .......... .......... .......... .......... .......... .......... .......
Sub-typeU .......... ..-....... .-----.... .......... .......... .......... ........K. E..DQ.K... ..QN..KE.. .......Malaria Journal 2004, 3:40 http://www.malariajournal.com/content/3/1/40
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that show a variable number of repeat units, GDRA(A/
D)GQPAA and ANGAGNQPG, respectively, with some
variant positions within the sequence [22,23]. These two
variants have a worldwide distribution, and locally their
distribution have been also correlated with climatic
gradients or with the Anophelines vector specificity [26].
Studies carried out in some Asian endemic countries, i.e.
South and North Korea, China, the Philippines, the Solo-
mon Islands and Thailand [27,15,28,12] suggest that CSP
has a limited value as a molecular marker for genetic var-
Distance tree (built with the neighbor-joining method) inferred from 443 nucleotide positions and 264 variable sites of CSP  gene Figure 4
Distance tree (built with the neighbor-joining method) inferred from 443 nucleotide positions and 264 variable sites of CSP 
gene. Numbers on the branches indicate bootstrap proportions (1000 replicates); only bootstrap values above 70 % are dis-
played on the tree.
South Korea AF316581
South Korea AF236847
South Korea AF436891
China U08979
South Korea AF236846
South Korea AF164608
China U08977
Min 1,3,9, Bey 1, 2, Imi 3, 5, 9, 10, 11, 12, 14, 15, Sat 2, 3, Sab 2, 4, 6, 7, 8, 10, 12, 13, 15 Sub-type 4*
Sab 1 Sub-type  7*
Min 10 Sub-type 6
Imi 8 Sub-type 1*
Bey 7 Sub-type 8*
Bey 14, Min 7, 8 Sub-type  2*
Min 6 Sub-type  3*
Bey 4, Sat 5, 7, 11 Sub-type  5*
VK210 M28746
Philippines U08980
Solomon Islands U08983
South Korea AF059336
Solomon Islands U08982
Thailand M34697
Belem M11926
Salvador J02751
VK247 M28745
Brasil M69062
South Korea AJ292977
South Korea AJ297403
South Korea AJ295636
South Korea AJ278611
South Korea AF236849
South Korea AJ400910
North Korea M20670
China U08978
100
82
100
94
91
87
99
100
100
100
99
100
100
99
77
81Malaria Journal 2004, 3:40 http://www.malariajournal.com/content/3/1/40
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Neighbour-joining tree from the MSP-1 and CSP data (results in parenthesis) reflecting the relationships between the Azerbai- jan P. vivax isolates Figure 5
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iability when used alone. In the present study, all the ana-
lysed  P. vivax isolates from Azerbaijan were found to
belong to the type VK210 and they constitute a group of
eight CSP sub-types that closely linked in the dendro-
gramme shown in Figure 4. Differently from what
reported by other Authors [28] who showed that the CSP
sequence analysis allows detecting the geographic origin
of plasmodial isolates, our results did not support its use
for tracking the geographic origin of Azeri isolates since
we dealt with a limited number of samples studied. No
genotype association with particular sampling districts
was observed since, for example, the most common sub-
type identified (G/4) was present in all five districts.
Our results confirmed that MSP-1 is a good polymorphic
marker. In particular, the region of the gene known to be
highly polymorphic and discriminative between the
Belem and Sal I types was analysed [23]. A variable poly-
glutamine (poly-Q) region is characteristic of the Belem
type and represents the principal source of genetic diver-
sity of this marker. Moreover, a poli-Q region is the
recombination site between the two types Belem and Sal I
and, as shown in the literature, interallelic recombina-
tions between the two types are frequent [25]. The total
genetic diversity observed when including the nucleotide
substitutions is relatively important taking into account
the low endemicity of studied area. Similar results were
observed in Southeastern Iran and in Thailand [29,12],
low endemic countries for P. vivax malaria as well, where
the authors detected the two types Belem and Sal I,
together with several recombinant types. In particular, in
the study carried out in Iran by Zakeri et al., the analysis of
MSP1 genetic diversity on a total of 16 plasmodial isolates
leaded to the identification of 14 genetic sub-types. It is
worth noting that such a high level of diversity is probably
due to the small sample size.
Our results show 17 genetic sub-types on a total of 36 iso-
lates analysed and a quite high MSP-1 polymorphism also
in Azerbaijan. As suggested in other studies [12] and also
reported by Zakeri et al., it is possible to speculate that the
observed genetic diversity could be also explained consid-
ering the studied area, i.e. central Azerbaijan, as transit
road of the country and also of neighboring Asian coun-
try, where the circulating P. vivax populations show con-
siderable MSP-1 genetic diversity. However, further
studies aimed at collecting more information about peo-
ple moving within the whole country and to closer coun-
tries are needed to verify the above hypothesis. The
combined analysis of CSP and MSP1 sequence
polymorphism has led to the identification of a total of 19
P. vivax sub-types, confirming that the simultaneous use
of more than one genetic marker in this kind of study
enhances the knowledge of genetic diversity existing in
the parasite populations. The results of the current study
show the circulation of multiple plasmodial clones in the
studied area thus leading to the conclusion that malaria
surveillance activities must be maintained in Azerbaijan
in order to avoid serious disease outbreaks in the future.
The understanding of the polymorphism extent in surface
antigens as CSP and MSP-1 and the resulting genetic
diversity in P. vivax field populations could help in imple-
menting malaria control activities being a crucial step for
the development of a malaria vaccine.
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